Cargando…
Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
There are two members of the vasohibin (VASH) family, VASH1 and VASH2. VASH1 is expressed mainly in endothelial cells to inhibit angiogenesis, whereas VASH2 is expressed mainly in cancer cells to stimulate tumor growth. The aim of the present study was to establish neutralizing monoclonal antibody (...
Autores principales: | Koyanagi, Takahiro, Suzuki, Yasuhiro, Komori, Kazuki, Saga, Yasushi, Matsubara, Shigeki, Fujiwara, Hiroyuki, Sato, Yasufumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378258/ https://www.ncbi.nlm.nih.gov/pubmed/28032401 http://dx.doi.org/10.1111/cas.13149 |
Ejemplares similares
-
Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
por: Takahashi, Yoshifumi, et al.
Publicado: (2016) -
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
por: TAKAHASHI, YOSHIFUMI, et al.
Publicado: (2015) -
Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013) -
The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010) -
Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer
por: Koyanagi, Takahiro, et al.
Publicado: (2021)